Tafalgie Therapeutics, a new start-up company, based on the work of Aziz Moqrich’s team
Tafalgie Therapeutics is a new start-up company created in November 2020, based on the work of Aziz Moqrich’s team “Chronic pain: cellular and molecular mechanisms” at IBDM.